168 related articles for article (PubMed ID: 10344757)
1. Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction.
Grassilli E; Salomoni P; Perrotti D; Franceschi C; Calabretta B
Cancer Res; 1999 May; 59(10):2451-6. PubMed ID: 10344757
[TBL] [Abstract][Full Text] [Related]
2. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
3. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
[TBL] [Abstract][Full Text] [Related]
6. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
[TBL] [Abstract][Full Text] [Related]
7. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity.
Salomoni P; Perrotti D; Martinez R; Franceschi C; Calabretta B
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3296-301. PubMed ID: 9096387
[TBL] [Abstract][Full Text] [Related]
8. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
9. B-myb alters the response of myeloid precursor cells to G-CSF.
Engelhard A; Campbell K; Calabretta B
Exp Cell Res; 2000 Jan; 254(1):153-62. PubMed ID: 10623475
[TBL] [Abstract][Full Text] [Related]
10. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
[TBL] [Abstract][Full Text] [Related]
12. Activation of Bcl-2 expression in human endothelial cells chronically expressing the human T-cell lymphotropic virus type I.
Nicot C; Astier-Gin T; Guillemain B
Virology; 1997 Sep; 236(1):47-53. PubMed ID: 9299616
[TBL] [Abstract][Full Text] [Related]
13. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
[TBL] [Abstract][Full Text] [Related]
14. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
16. c-Myb function in fibroblasts.
Bein K; Husain M; Ware JA; Mucenski ML; Rosenberg RD; Simons M
J Cell Physiol; 1997 Dec; 173(3):319-26. PubMed ID: 9369944
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of the interleukin (IL)-2 receptor alpha chain (CD25) promoter region in human B lymphocytes.
Hewitt EL; Ozanne BW; Cushley W
Cytokine; 1997 Dec; 9(12):982-91. PubMed ID: 9417809
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
19. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
20. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
